=== Harm Reduction ===
==== Forms & Identification ====
NM-2-AI's simple chemical structure does not produce distinctive color changes with common [[glossary:reagent-kit|reagent test kits]] (Marquis, Mecke, Mandelin), making field identification unreliable. A negative or ambiguous reagent result does not confirm identity — it only rules out some other substance classes. For NM-2-AI specifically, [[glossary:laboratory-analysis]] (GC-MS or similar) is the only reliable confirmation method.
Because NM-2-AI originates entirely from unregulated [[glossary:synthesis]], batch purity varies unpredictably. The compound has been found in forensic [[glossary:seizure|seizures]] alongside other [[glossary:novel-psychoactive-substance|novel psychoactive substances]]{{cite|doi=10.1016/j.forsciint.2016.01.037|anchor=7bb852c3}}, raising the possibility of [[glossary:contamination]] or mislabeling in vendor supply.
==== Set & Setting ====
NM-2-AI's noradrenergic pharmacology produces a physically driven, alert state. Social environments may draw out mild prosocial effects; solitary use tends to amplify the restless, jittery quality. The short duration (2–4 hours) and abrupt offset create strong psychological pressure to [[glossary:redose]] — planning a firm dose limit before the session begins is more effective than deciding in the moment.
The [[substance_class:psychoactive/stimulant]] [[glossary:body-load]] (elevated [[glossary:heart-rate]], physical tension) can become uncomfortable in hot, crowded, or physically demanding settings. A calm environment with access to water and fresh air reduces physiological strain.
{{Guideline}}
==== Guidelines ====
* Test substance identity with reagent kits to rule out dangerous substitutions, and ideally confirm with laboratory analysis
* Weigh doses with a milligram-precision scale — volumetric estimation of powders is unreliable
* Set a firm dose limit and timing plan before the session; do not carry extra material
* Start at the low end of the reported [[glossary:dose-range]] and wait at least 90 minutes before considering a redose
* Stay hydrated but avoid overhydration — moderate sipping, not forced water intake
* Avoid use in hot environments or during intense physical activity
* Have a trusted person aware of what you have taken and when
* Do not combine with MAOIs, [[substance:tramadol]], [[substance:mdma]], or other stimulants
{{/Guideline}}
{{Emergency}}
==== Emergency Response ====
'''Recognizing an emergency:'''
* [[glossary:chest-pain]] or pressure
* Seizure or convulsions
* [[glossary:body-temperature]] so high it can be felt through clothing
* [[glossary:loss-of-consciousness]] or unresponsiveness
* Severe [[effect:confusion]], [[effect:paranoia]], or [[glossary:self-harm]] behavior
An elevated heart rate and mild [[effect:anxiety]] alone do not constitute an emergency — chest pain, seizure, and extreme body temperature do.
'''Immediate steps:'''
* 1. Call emergency services if any of the above signs are present
* 2. Move the person to a cool, quiet area
* 3. If unconscious but breathing, place in the [[glossary:recovery-position]] (on their side)
* 4. Do not restrain a conscious person unless there is immediate danger of self-harm
* 5. Do not induce [[effect:vomiting]]
* 6. Stay with the person until help arrives
'''What to tell the dispatcher:'''
Name the substance (NM-2-AI / N-methyl-[[substance:2-aminoindane]]), the estimated amount taken, the time of [[glossary:ingestion]], and current symptoms. [[glossary:good-samaritan-law|Good Samaritan laws]] in many jurisdictions protect people who call for help during a [[glossary:drug-emergency]].
{{/Emergency}}
{{Aftercare}}
==== Aftercare & Integration ====
The stimulant comedown from NM-2-AI involves [[glossary:depletion|monoamine depletion]] — expect [[glossary:fatigue]], low mood, and [[effect:irritability]] in the 12–48 hours following use. Sleep is the most effective recovery tool; if stimulant residue prevents sleep, a dark quiet room and avoidance of screens help more than additional substances.
Nutrient replenishment matters: eat a full meal within a few hours of the experience ending, prioritizing protein and complex carbohydrates. Magnesium supplementation may help with residual [[effect:muscle-tension]].
If compulsive redosing occurred during the session, treat this as information — it reflects the compound's pharmacological profile, not personal failure, and it should factor into future decisions about use.
{{/Aftercare}}
{{Recovery}}
==== Recovery & Support ====
NM-2-AI's moderate [[glossary:dependence]] potential and compulsive redosing profile mean that patterns of escalating use can develop without the dramatic [[glossary:withdrawal]] seen with stronger stimulants. If use has become more frequent than intended, or if obtaining and using the substance occupies increasing mental bandwidth, these are early signals worth taking seriously.
[[glossary:peer-support]] communities, including online [[index:harm-reduction|harm reduction]] forums and local mutual aid groups, provide non-judgmental spaces to discuss stimulant use patterns. Professional support through a [[glossary:substance-use]] counselor is appropriate when self-regulation efforts have not been effective. SAMHSA's National Helpline (1-800-662-4357) offers free, confidential [[glossary:referral]] in the United States.
{{/Recovery}}